Adma Biologics, Inc.
Ramsey, NJ
- UEI
- KJGJMLX7UYT1
- CAGE
- 8NML8
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 465 NJ-17, Ramsey, NJ 07446, USA
- Website
- admabiologics.com
- Founded
- 2004
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
| TG Therapeutics Inc. | Morrisville, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Summit SD LLC | Lee's Summit, MO | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Richmond Pharmaceuticals, Inc. | Richmond, VA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Adma Biologics, Inc., doing business as Adma Biologics, is a registered entity in the U.S. federal government's System for Award Management (SAM.gov) since July 17, 2020. As a for-profit corporate entity, Adma Biologics specializes in providing pharmaceutical and hematology-related products to federal agencies, particularly the Department of Veterans Affairs. The company's focus appears to be on plasma-derived therapeutics, with specific products mentioned including ASCENIV and BIVIGAM. These specialized pharmaceuticals suggest that Adma Biologics plays a crucial role in supplying critical medical products to support healthcare operations within the federal government.
Adma Biologics holds multiple federal contract Indefinite Delivery Vehicles (IDVs) that demonstrate its significant involvement in government procurement. The company has been awarded a Blanket Purchase Agreement (BPA) with a substantial ceiling value of $49,000,000, set to run through July 31, 2025. This BPA, awarded by the National Acquisition Center, specifically covers the procurement of ASCENIV and BIVIGAM. Additionally, Adma Biologics holds two Federal Supply Schedule (FSS) contracts. One FSS contract, with a ceiling value of $1,549,720 and running until July 14, 2029, is for supplying drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12). Another FSS contract, albeit smaller with a $25,000 ceiling, provides similar products through July 14, 2024. These contracts collectively enable various agencies, particularly within the Veterans Health Administration, to streamline their procurement of essential pharmaceutical and hematological products from Adma Biologics.
Quick answers
Is Adma Biologics, Inc. registered in SAM.gov?
Yes. Adma Biologics, Inc.'s SAM.gov registration is active through September 23, 2027.
What is Adma Biologics, Inc.'s CAGE code?
Adma Biologics, Inc.'s CAGE code is 8NML8, and its Unique Entity ID (UEI) is KJGJMLX7UYT1.
Which contract vehicles does Adma Biologics, Inc. hold?
Adma Biologics, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Adma Biologics, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors